Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
Greater China-based platform with an Asia-wide outlook, best known for its expertise advising on private equity matters, with a focus on take-private deals. It acts for both local and international funds on complex matters. Also known for its expertise in US, Hong Kong and cross-border public M&A and venture capital investments. Notable deal experience on transactions in the TMT, life sciences, energy, education and hospitality sectors
"We think Weil’s performance on the deal was super, top-rate. The deal was cross-border and very complicated, and we were completely satisfied with their work," reveals a client, going on to say: "They were very hands-on and always available to work through issues, keeping our commercial goals and risks in mind. When we had differences with the other side, they always took the extra steps to come up with commercial solutions so that both sides could solve the differences and move forward with the deal."
Another source is equally impressed with the team's client-oriented approach, noting: "With Weil you know you will always get full effort and top-quality, commercial advice to help get difficult deals done. We can tell the service level is very high, and the team are fully dedicated to the client and the deal. They are very commercial and know what issues to stand firm on and what issues can be resolved with creative solutions."
"The Weil team is technically very strong, from top to bottom," opines a client, going on to add: "The quality of their advice, written and oral, really sets them apart from their competitors. Their partners are extremely hands-on and responsive, and provide commercial and pragmatic advice."
Another client is equally impressed by the continuity in the team, noting: "The quality of Weil’s work and their grasp of the detail in our transaction was very impressive, given the complexity. The lawyers on the team, both partners and counsel, are highly responsive and their advice was top-notch."
Acted for Alibaba on its USD2 billion acquisition of Kaola, an e-commerce platform, from NetEase.
Advised Hillhouse Capital, as a member of a consortium, on the USD4.6 billion take-private of China Biologic Products.
Key corporate partner Charles Ching manages the Shanghai and Beijing offices and Tim Gardner the Hong Kong office.
This content is provided by Weil, Gotshal & Manges LLP.
To learn more about our M&A practice, please visit: https://www.weil.com/experience/practices/mergers-and-acquisitions
To learn more about our private equity practice, please visit: https://www.weil.com/experience/practices/private-equity